Search results for "mening"

showing 10 items of 254 documents

Suprasellar Granular Cell Tumor

1992

A case of a suprasellar granular cell tumor, approximately 1.5 cm in diameter, in a 68-year-old woman is described. Diagnosis was established postoperatively by histopathological examination of the tumor tissue. The preoperative computed tomographic scan revealed a slightly hyperdense suprasellar mass with strong contrast enhancement. There was no evidence of calcification. The T1-weighted image on magnetic resonance imaging scan showed an isointense tumor with non-homogeneous enhancement after intravenous gadolinium diethylene-triamine-pentaacetic acid. In the proton-weighted image, the suprasellar mass presented a non-homogeneously enhanced signal. A non-homogeneous signal reduction was s…

Microsurgeryendocrine system diseasesGadoliniummedicine.medical_treatmentchemistry.chemical_elementPituitary neoplasmCytoplasmic GranulesDiagnosis DifferentialMeningiomaMeningesMeningeal NeoplasmsmedicineHumansPituitary NeoplasmsAgedGranular cell tumormedicine.diagnostic_testbusiness.industryMagnetic resonance imagingAnatomyMicrosurgerymedicine.diseaseMagnetic Resonance ImagingMicroscopy ElectronchemistryPituitary GlandFemaleSurgeryNeurology (clinical)Differential diagnosisMeningiomaNuclear medicinebusinessCalcificationNeurosurgery
researchProduct

Copper(II)-Induced Restructuring of ZnuD, a Zinc(II) Transporter from Neisseria meningitidis.

2019

Cluster 2 (288HDDDNAHAHTH298) from Neisseria meningitidis ZnuD is a flexible loop that captures zinc(II) ions, acting as a "fishing net". We describe its Zn(II) and Cu(II) binding capabilities, focusing on the thermodynamics of such interactions and comparing them with the complexes of the 1MAHHHHHHL9-NH2 region. Copper(II) complexes with the studied ZnuD regions are thermodynamically more stable than the zinc(II) ones-Cu(II) complexes dominate in solution even in close to physiological ratios of the studied metal ions (a 10-fold excess of Zn(II) over Cu(II)). While the binding of native Zn(II) has no significant impact on the structure of its transporter, Cu(II) binding induces a conformat…

Models MolecularConformational changeMetal ions in aqueous solutionchemistry.chemical_elementZincNeisseria meningitidis010402 general chemistry01 natural sciencesInorganic ChemistryBacterial ProteinsHumansProlineAmino Acid SequencePhysical and Theoretical ChemistryCation Transport ProteinsPolyproline helix010405 organic chemistryTransporterCopper0104 chemical sciencesMeningococcal InfectionsCrystallographyZincchemistryHelixThermodynamicsCopperProtein BindingInorganic chemistry
researchProduct

The triad hsp60-mirnas-extracellular vesicles in brain tumors: Assessing its components for understanding tumorigenesis and monitoring patients

2021

Brain tumors have a poor prognosis and progress must be made for developing efficacious treatments, but for this to occur their biology and interaction with the host must be elucidated beyond current knowledge. What has been learned from other tumors may be applied to study brain tumors, for example, the role of Hsp60, miRNAs, and extracellular vesicles (EVs) in the mechanisms of cell proliferation and dissemination, and resistance to immune attack and anticancer drugs. It has been established that Hsp60 increases in cancer cells, in which it occurs not only in the mitochondria but also in the cytosol and plasma-cell membrane and it is released in EVs into the extracellular space and in cir…

Molecular chaperonesCellBrain tumorBiologymedicine.disease_causelcsh:Technologylcsh:Chemistry03 medical and health sciences0302 clinical medicineImmune systemHigh-grade gliomaExtracellularmedicineGeneral Materials Sciencelcsh:QH301-705.5Instrumentation030304 developmental biologyFluid Flow and Transfer Processes0303 health sciencesLiquid biopsylcsh:TProcess Chemistry and TechnologyGeneral EngineeringCancerTumor biomarkersChaperonopathiesExtracellular vesiclesmedicine.diseaseHsp60lcsh:QC1-999Computer Science ApplicationsCrosstalk (biology)medicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040030220 oncology & carcinogenesisCancer cellCancer researchChaperone systemMiRNAslcsh:Engineering (General). Civil engineering (General)CarcinogenesisGlioblastomaMeningiomalcsh:Physics
researchProduct

Withdrawal of a mumps vaccine.

1994

Mumps vaccinebusiness.industryImmunization ProgramsPediatrics Perinatology and Child HealthMedicineHumansMumps VaccinebusinessVirologyMeningitis ViralUnited KingdomEuropean journal of pediatrics
researchProduct

Current standing and frontiers of gene therapy for meningiomas

2013

Meningiomas are among the most common intracranial tumors. The treatment of choice for these lesions is complete resection, but in 50% of cases it is not achieved due to tumor location and/or surgical morbidities. Moreover, benign meningiomas have high recurrence rates of up to 32% in long-term follow-up. Molecular analyses have begun to uncover the genetics behind meningiomas, giving rise to potential genetics-based treatments, including gene therapy. The authors performed a literature review on the most relevant genes associated with meningiomas and both current and potential gene therapy strategies to treat these tumors. Wild-type NF2 gene insertion, oncolytic viruses, and transfer of si…

Neurofibromatosis 2medicine.medical_specialtyAngiogenesisGenetic enhancementGenetic TherapyGeneral MedicineBiologymedicine.diseaseOncolytic virusMeningiomaClinical trialBenign MeningiomaMeningeal Neoplasmsotorhinolaryngologic diseasesmedicineCancer researchHumansSurgeryNeurology (clinical)NeurosurgeryMeningiomaGeneSignal TransductionNeurosurgical Focus
researchProduct

P03.04 Signaling questions assessing brain tumor patients’ distress in clinical routine - a feasibility study

2019

Abstract BACKGROUND Approximately 20%-35% of patients with intracranial tumors show depressive symptoms and distress. Assessment in these patients remains challenging due to cognitive and/or neurological deficits. We developed 3 signaling questions in order to assess patients during patient-doctor consultation. The aim is to implement them in clinical routine and to compare the results with patient reported outcome measures (PROMs) along disease trajectory. MATERIAL AND METHODS Patients were prospectively examined in a structured interview applying the 3 following questions: 1),Has your mood worsened? (I)”; 2),Are you strained by physical changes? (II)”; 3),Has your faculty of thought decre…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryBrain tumormedicine.diseaseMeningiomaPoster PresentationsDistressMoodOncologyInformed consentGliomaInternal medicineStructured interviewmedicineAdjuvant therapyNeurology (clinical)business
researchProduct

Aprūpes problēmas pacientiem ar meningīta saslimšanu

2017

Bakalaura darbs ”Aprūpes problēmas pacientiem ar meningīta saslimšanu” izstrādāts Latvijas Universitātes Medicīnas fakultātes Profesionālā bakalaura studiju programmas ietvaros. Kā teorētiskais pamats izmantota V.Hendersones Pamatvajadzības māszinības teorija. Pētījums ir realizēts ar mērķi izpētīt aprūpes problēmas pacientiem ar meningīta saslimšanu. Pētījuma uzdevumi ir zinatniskās literatūras par meningīta saslimšanu un māszinības teorijas analīzešana un apkopošana, datu vākšana, apstrāde un analīze, rezultātu apzināšana un interpretācija, apkopot iegūtos rezultātus un veikt secinājumus. Pētniecības jautājums: Kādas aprūpes problēmas ir pacientiem ar meningīta saslimšanu? Pētījumā tika i…

Pacientu aprūpeNovērošanaMeningītsMedicīna
researchProduct

Seizure in isolated brain cryptococcoma: Case report and review of the literature

2021

Background: Central nervous system (CNS) cryptococcosis is an invasive fungal infection predominantly seen among immunosuppressed patients causing meningitis or meningoencephalitis. Rarely, cryptococcosis can affect immunologically competent hosts with the formation of localized CNS granulomatous reaction, known as cryptococcoma. Common symptoms of CNS cryptococcoma are headaches, consciousness or mental changes, focal deficits, and cranial nerve dysfunction. Rarely, seizures are the only presenting symptom. Case Description: We report the case of an immunocompetent patient with a solitary CNS cryptococcoma presenting with a long history of non-responsive generalized seizure who has been s…

Pathologymedicine.medical_specialtyCentral nervous systemCase ReportSeizure.03 medical and health sciences0302 clinical medicineCryptococcomaMedicine030212 general & internal medicineCranial nerve dysfunctionbusiness.industryMeningoencephalitisIsolated brainmedicine.diseaseSeizurePathophysiologymedicine.anatomical_structureCentral nervous systemCryptococcosisSurgeryNeurology (clinical)Headachesmedicine.symptombusinessMeningitis030217 neurology & neurosurgerySurgical Neurology International
researchProduct

Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation

2020

Abstract Primary meningeal melanocytomas are rare tumors of the central nervous system. Although they are considered benign neoplasms, some reports describe recurrent rates up to 45%. Little is known about their genetic and epigenetic landscape because of their infrequency. Even less has been described about markers with prognostic value. Here we describe a patient who developed a primary meningeal melanocytoma, suffered 3 recurrences in a period of 6 years and died of the tumor. The genetic and epigenetic changes explored confirmed GNAQ mutation as an initiating event. We found an epigenetic alteration of GSTP1, a feature that has recently been described in meningiomas, from the beginning …

Pathologymedicine.medical_specialtyMitotic indexProliferation indexDiseasePathology and Forensic MedicineMeningiomaLoss of heterozygosity03 medical and health sciencesCellular and Molecular NeuroscienceFatal Outcome0302 clinical medicineMeningeal NeoplasmsmedicineHumansEpigeneticsMelanomaCell ProliferationBRCA1 Proteinbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseGlutathione S-Transferase piNeurology030220 oncology & carcinogenesisMutationGTP-Binding Protein alpha Subunits Gq-G11FemaleNeurology (clinical)Neoplasm Recurrence LocalMelanocytomabusiness030217 neurology & neurosurgeryGNAQJournal of Neuropathology & Experimental Neurology
researchProduct

Oral Rhabdomyosarcoma: a review

2012

Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm comprised of cells derived from the primitive mesen¬chyme. About 35% of RMS arises in the head and neck, are are classified as parameningeal and non-parameningeal forms. These are the most common soft tissue sarcoma of the children, adolescents and young adults. Their etiopathogenesis and its molecular relevance have been emphasized. The first line of treatment is radical excision and this is usually supplemented by radiotherapy. It is believed that adjunct combination chemotherapy may greatly improve the prognosis. Inadequately treated tumours grow in an infiltrative manner and recur in a high percentage of cases. Bone does no…

Pathologymedicine.medical_specialtyOral Medicine and Pathologybusiness.industryFirst linemedicine.medical_treatmentSoft tissue sarcomaCombination chemotherapyMalignant Soft Tissue NeoplasmParameningealOdontologíaReviewmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludRadiation therapyUNESCO::CIENCIAS MÉDICASMedicinebusinessHead and neckRhabdomyosarcomaGeneral Dentistry
researchProduct